ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.

Biotechnology

ImmunityBio

Rich Adcock

Philip Loscalzo

Regan Lauer

Helen Luu

Patrick Soon-Shiong

Barry Simon

Jason Liljestrom

Sarah Singleton

Leonard S. Sender

David Sachs

The Research and Development team at ImmunityBio focuses on advancing cell and immunotherapy products by innovating new treatments to bolster the body's immune response against diseases such as cancer. Their work involves developing vaccines, pioneering cell therapies, and translating scientific discoveries into clinical applications to enhance patient outcomes.

Research and Development

Executive Team

Leadership Team

Research and Development

About

Team members

Other teams at ImmunityBio

Executive Team

Leadership Team